Gilead Sciences delivered a breakout performance Friday, surging 8.3% to $119.41 in its strongest single-day gain in nearly ...

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...

U.S. stocks are drifting near their record heights as Wall Street waits for an upcoming update on inflation.

Deutsche Bank analyst James Shin raised the firm’s price target on Gilead (GILD) to $135 from $120 and keeps a Buy rating on the shares.Elevate Your Investing Strategy: Take advantage of TipRanks ...

A wave of factory closures is reshaping regional economies, displacing skilled laborers and weakening supply chains.

Gift Nifty was trading 24,447 around level, a premium of nearly 6 points from the Nifty futures’ previous close, indicating a ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

Dorothy L. Holbrook, age 91, of Galion passed away Sunday August 10, 2025 at Trustwell Living in Mansfield. Born January 5, 1934 in Ivyton, KY, she was the daughter of the late Will and Molly ...

September S&P 500 E-Mini futures (ESU25) are up +0.09%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.05% this ...

Instead of confronting the structural forces that create and sustain homelessness, these strategies shift responsibility onto ...